#visualabstract — Public Fediverse posts
Live and recent posts from across the Fediverse tagged #visualabstract, aggregated by home.social.
-
cool example of fixing #confounding - antibiotics and stone edition (no, it ain't any fancy regression or propensity score matching)
https://journals.lww.com/jasn/Fulltext/2023/08000/Outpatient_Antibiotic_Use_is_Not_Associated_with.11.aspx in JASN with a #VisualAbstract from @CorinaT #Epidemiology
-
cool example of fixing #confounding - antibiotics and stone edition (no, it ain't any fancy regression or propensity score matching)
https://journals.lww.com/jasn/Fulltext/2023/08000/Outpatient_Antibiotic_Use_is_Not_Associated_with.11.aspx in JASN with a #VisualAbstract from @CorinaT #Epidemiology
-
cool example of fixing #confounding - antibiotics and stone edition (no, it ain't any fancy regression or propensity score matching)
https://journals.lww.com/jasn/Fulltext/2023/08000/Outpatient_Antibiotic_Use_is_Not_Associated_with.11.aspx in JASN with a #VisualAbstract from @CorinaT #Epidemiology
-
cool example of fixing #confounding - antibiotics and stone edition (no, it ain't any fancy regression or propensity score matching)
https://journals.lww.com/jasn/Fulltext/2023/08000/Outpatient_Antibiotic_Use_is_Not_Associated_with.11.aspx in JASN with a #VisualAbstract from @CorinaT #Epidemiology
-
cool example of fixing #confounding - antibiotics and stone edition (no, it ain't any fancy regression or propensity score matching)
https://journals.lww.com/jasn/Fulltext/2023/08000/Outpatient_Antibiotic_Use_is_Not_Associated_with.11.aspx in JASN with a #VisualAbstract from @CorinaT #Epidemiology
-
An excellent #VisualAbstract from Mythri Shankar on the #WorldKidneyDay theme of “Preparing for the Unexpected, Supporting the Vulnerable”
-
The rationale and design of the APPLAUSE IgAN trial of #iptacopan - a complement inhibitor - in #IgANephropathy - funded by its maker Novartis
Well timed for #NephMadness #IgANephropathy region! With a great #VisualAbstract from @edgarvlermamd
https://www.sciencedirect.com/science/article/pii/S2468024923000505
-
The next edition of #NephTrials on master trial protocols, with a focus on #BasketTrials using the #RENALLIFECYCLES example http://www.nephjc.com/news/master-trials in #Flozins
With a great #VisualAbstract from Denisse Arellano from the ISN social media team
-
Tonight and tomorrow on #NephJC we discuss the NEFIGARD trial of #Nefecon (a targeted release #budesonide) in #IgANephropathy - supposedly with no systemic steroid exposure - but read the summary and decide for yourself http://www.nephjc.com/news/nefigard-trial
#nephrology #glomerulonephritis
#VisualAbstract from @Priti899
-
Tonight and tomorrow on #NephJC we discuss the NEFIGARD trial of #Nefecon (a targeted release #budesonide) in #IgANephropathy - supposedly with no systemic steroid exposure - but read the summary and decide for yourself http://www.nephjc.com/news/nefigard-trial
#nephrology #glomerulonephritis
#VisualAbstract from @Priti899
-
Tonight and tomorrow on #NephJC we discuss the NEFIGARD trial of #Nefecon (a targeted release #budesonide) in #IgANephropathy - supposedly with no systemic steroid exposure - but read the summary and decide for yourself http://www.nephjc.com/news/nefigard-trial
#nephrology #glomerulonephritis
#VisualAbstract from @Priti899
-
Tonight and tomorrow on #NephJC we discuss the NEFIGARD trial of #Nefecon (a targeted release #budesonide) in #IgANephropathy - supposedly with no systemic steroid exposure - but read the summary and decide for yourself http://www.nephjc.com/news/nefigard-trial
#nephrology #glomerulonephritis
#VisualAbstract from @Priti899
-
Tonight and tomorrow on #NephJC we discuss the NEFIGARD trial of #Nefecon (a targeted release #budesonide) in #IgANephropathy - supposedly with no systemic steroid exposure - but read the summary and decide for yourself http://www.nephjc.com/news/nefigard-trial
#nephrology #glomerulonephritis
#VisualAbstract from @Priti899